4-methyl-2,6-diisobornylphenol
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Excretion of highly lipophilic (log P = 8.14) 4-methyl-2,6-diisobornylphenol (IBP) from rats was evaluated from renal excretion…
We compared bioavailability of 4-methyl-2,6-diisobornylphenol after single intragastric administration to rats in a dose of 200…
We have studied the distribution of the new compound 4-methyl-2,6-diisobornylphenol in rats after a single oral administration in…
The linearity of pharmacokinetics of 4-methyl-2,6-diisobornylphenol after single intragastric administration in doses within 10…
The pharmacokinetics of 4-methyl-2,6-diisobornylphenol (MDIBP) in rat blood plasma has been studied after intravenous injection…
Methods for monitoring the quality of the new pharmaceutical substance 4-methyl-2,6-diisobornylphenol (dibornol) were developed.
Hemorheological and antiaggregant properties of new o-isobornylphenol derivatives were investigated in ex vivo experiments. 4…
Along with microangiopathy, one of the main causes of blindness in diabetic retinopathy consists of degeneration of retinal…
Neuroprotective activity of the new sterically hindered phenolic antioxidant 4-methyl-2,6-diisobornylphenol (dibornol) in rats…
Along with microangiopathy, degeneration of retinal neurons is one of the basic causes of blindness in patients with diabetic…